RenovoRx maintains $3.75M-$4.25M 2026 revenue guidance as it targets 36 active cancer centers
Open the sourceReported by Seeking Alpha, seekingalpha.com, 6 November 2026
Not scored
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.